Cargando…

Side effects of a dopamine agonist therapy for Parkinson’s disease: a mini-review of clinical pharmacology

Dopamine agonists (DA) are therapeutic agents that are commonly used in the treatment of Parkinson’s disease (PD). They can reduce undesired motor fluctuations and delay the administration of levodopa therapy. However, this drug family is associated with specific side effects that can significantly...

Descripción completa

Detalles Bibliográficos
Autor principal:	Borovac, Josip Anđelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	YJBM 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797835/ https://www.ncbi.nlm.nih.gov/pubmed/27505015

Ejemplares similares

Treatment of Persistent Left Atrial Appendage Thrombus in Patients with Atrial Fibrillation on Adequate Oral Anticoagulation: Pathways of Care for All-comers and Heart Failure Patients
por: Katic, Josip, et al.
Publicado: (2023)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

The impact of antithrombotic therapy on the time of detection of bladder cancer
por: Jakus, Dora, et al.
Publicado: (2022)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Neoatherosclerosis and Late Thrombosis After Percutaneous Coronary Intervention: Translational Cardiology and Comparative Medicine from Bench to Bedside   
por: Borovac, Josip Anđelo, et al.
Publicado: (2017)

Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists
por: Mohammad, Mohammad Edrees, et al.
Publicado: (2021)

Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers
por: Borovac, Josip Anđelo, et al.
Publicado: (2020)

A global amnesia associated with the specific variant of posterior reversible encephalopathy syndrome (PRES) that developed due to severe preeclampsia and malignant hypertension
por: Borovac, Josip Anđelo, et al.
Publicado: (2016)

Dopamine agonist monotherapy utilization in patients with Parkinson’s disease
por: Frazer, Monica, et al.
Publicado: (2022)

Awareness, attitudes, barriers, and knowledge about evidence-based medicine among family physicians in Croatia: a cross-sectional study
por: Nejašmić, Danijel, et al.
Publicado: (2020)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Data Collection Theory in Healthcare Research: The Minimum Dataset in Quantitative Studies
por: Kwok, Chun Shing, et al.
Publicado: (2022)

The electrocardiographic and angiographic discrepancy in determining culprit coronary artery lesion: anterior ST-T segment changes within the context of inferior wall acute myocardial infarction
por: Borovac, Josip Andelo, et al.
Publicado: (2023)

Mediterranean Diet Adherence and Dietary Attitudes in Patients with Inflammatory Bowel Disease
por: Vrdoljak, Josip, et al.
Publicado: (2020)

Causes and factors related to dopamine agonist withdrawal in Parkinson′s disease
por: Castro, Ester Suárez, et al.
Publicado: (2016)

Dopamine Agonist-Associated Hiccup in Parkinson’s Disease: A Case Report
por: EMEKLİ, Ahmed Serkan, et al.
Publicado: (2019)

Feasibility and safety of catheter-directed thrombolysis via superficial cubital vein for the treatment of acute massive and submassive pulmonary embolism
por: Giunio, Lovel, et al.
Publicado: (2021)

The Impact of Concomitant Diagnosis of Viral Infections on In-Hospital Mortality in Patients Hospitalized with a Diagnosis of Heart Failure in the United States: Insights from the National Inpatient Sample
por: Kwok, Chun Shing, et al.
Publicado: (2022)

Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist
por: Zhang, Jinglin, et al.
Publicado: (2016)

Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
por: Picillo, Marina, et al.
Publicado: (2020)

The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson’s disease: an observational study
por: Pellicano, Clelia, et al.
Publicado: (2013)

Compulsive Drumming Induced by Dopamine Agonists in Parkinson’s Disease: Another Aspect of Punding
por: Vitale, Carmine, et al.
Publicado: (2013)

No Dopamine Agonist Modulation of Brain [(18)F]FEOBV Binding in Parkinson’s Disease
por: Albin, Roger L., et al.
Publicado: (2022)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis
por: Thorlund, Kristian, et al.
Publicado: (2014)

Non-pharmacological Treatment Challenges in Early Parkinson's Disease for Axial and Cognitive Symptoms: A Mini Review
por: Sharpe, Gabriella, et al.
Publicado: (2020)

Prevalence of hypersexual behavior in Parkinson’s disease patients: Not restricted to males and dopamine agonist use
por: Cooper, Christine A, et al.
Publicado: (2009)

Dopamine D(1) Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease
por: Lewis, Mechelle M., et al.
Publicado: (2023)

Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study
por: Ecker, Daniel, et al.
Publicado: (2009)

The effect of a combined intervention on exclusive breastfeeding in primiparas: A randomised controlled trial
por: Puharić, Drita, et al.
Publicado: (2020)

Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist
por: Sumi, Satoko, et al.
Publicado: (2022)

The Comparative Efficacy of Non-ergot Dopamine Agonist and Potential Risk Factors for Motor Complications and Side Effects From NEDA Use in Early Parkinson's Disease: Evidence From Clinical Trials
por: Wu, Chunxiao, et al.
Publicado: (2022)

Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
por: Blum, Kenneth, et al.
Publicado: (2015)

Music Therapy for Gait and Speech Deficits in Parkinson’s Disease: A Mini-Review
por: Fan, Leon, et al.
Publicado: (2023)

Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson’s disease
por: van der Vegt, Joyce P.M., et al.
Publicado: (2020)

Revascularização com Bypass Coronário em Síndromes Coronarianas Agudas sem Supradesnivelamento do Segmento ST: Uma Instantânea de Ensaios e Registros Randomizados
por: Borovac, Josip Andelo, et al.
Publicado: (2022)

Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation
por: Bandettini di Poggio, Monica, et al.
Publicado: (2013)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019)

The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study
por: Ke, Xiaoan, et al.
Publicado: (2022)

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
por: Adhikari, Pramisha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tgclq13ogi571qu6m4oln85nib